ArticleBriefings in bioinformatics2025
MCAMEF-BERT: an efficient deep learning method for RNA N7-methylguanosine site prediction via multi-branch feature integration.
Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- A token-pruning framework enables efficient representation of the human genome for RNA modification analysis.Bioinformatics (Oxford, England) · 2026Article
- CMA-Nano: A DNA Methylation Detection Method for Nanopore Sequencing Data Based on a Cross-Modal Attention Mechanism.ACS omega · 2026Article
- N7-Methylguanosine Modification in Colorectal Cancer: Molecular Insights and Clinical Implications.International journal of molecular sciences · 2026Review
- EvoRMD: integrating biological context and evolutionary RNA language models for interpretable prediction of RNA modifications.Genome biology · 2026Article
- From nucleotides to numbers: a comprehensive review of RNA feature extraction methods for computational modelling.Briefings in bioinformatics · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Accurate identification of N7-methylguanosine (m7G) modification sites plays a critical role in uncovering the regulatory mechanisms of various biological processes, including human development, tumor initiation, and progression. However, existing prediction methods still suffer from limited representational power, redundant feature fusion, insufficient utilization of biological prior knowledge, and poor interpretability. In this study, we propose a novel deep learning model named MCAMEF-BERT. This model adopts a parallel architecture that integrates both a DNABERT-2-based pretrained model branch and multiple traditional feature encoding branches, enabling comprehensive multi-perspective sequence feature extraction. To address the redundancy issue in feature fusion, we introduce a multi-channel attention module. Our model demonstrates superior accuracy and effectiveness on datasets from m7GHub, outperforming other state-of-the-art classifiers. Furthermore, we validate the interpretability of MCAMEF-BERT through in silico saturation mutagenesis experiments, and confirm its robustness in motif recognition. Moreover, its generalization capability is validated across diverse RNA modification site prediction tasks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.